Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

115.06 +2.34 (+2.08%)
Streaming Delayed Price Updated: 2:26 PM EDT, Sep 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
3 No-Brainer Stocks to Buy in December
These are no-brainer stocks to buy regardless of whether we are in a bull or bear market. Strong tailwinds continue to push them forward. 
Via InvestorPlace
Becton Dickinson Recall Certain Infusion Pumps Due To Compatibility Issues With Cardinal Health's Monoject Syringes
Friday, the FDA said that Becton, Dicki 
Via Benzinga
How Is The Market Feeling About Cardinal Health?
Via Benzinga
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here. 
Via Benzinga
Jim Cramer Bullish On Boeing In Latest 'Lightning Round': 'This Is Their Year'
Cramer's optimism about Boeing follows his previous praise for the company in April 2023, when he referred to it as "really incredible." 
Via Benzinga
Peering Into Cardinal Health's Recent Short Interest
Via Benzinga
Earnings Outlook For Cardinal Health
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
JP Morgan Maintains Neutral Rating for Cardinal Health: Here's What You Need To Know
Via Benzinga
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
Amazon.Com, Inc. (NASDAQ: AMZN) has received a  
Via Benzinga
Exposures Product Safety
Dividend Income Update October 2023
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
Royal Rule: Buy These 3 Dividend Aristocrats on Every. Single. Dip.
Choosing dividend aristocrats to buy becomes easy when you elect to buy the royalty of income-generating stocks. 
Via InvestorPlace
Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High
Via Investor Brand Network
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
Bulls are back in control as the major indexes confirmed the uptrend this week. 
Via Investor's Business Daily
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Cardinal Health Inc. (NYSE: CAH) Records 52-Week High Friday Morning
Via Investor Brand Network
Major Healthcare Service Provider Cardinal Health Issues Upbeat Outlook, Shares Rise
Cardinal Health Inc (NYSE: CAH) reported  
Via Benzinga
Nasdaq, S&P 500 Futures Drop As Apple Guidance Disappoints: Analyst Says 'Seasonal Rally' Right On Queue
Apple's weak forecast has cast a pall of gloom on the market, although the monthly jobs report could determine the day's trading direction. 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For November 3, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
Fear & Greed Index Remains In 'Fear' Zone; Dow Notches Best Day Since June
The CNN Money Fear and Greed index remained in the "Fear" zone on Thursday. U.S. stocks closed sharply higher on Thursday, amid a decline in Treasury yields. The Dow Jones jumped more than 550 points,... 
Via Benzinga
Topics Stocks
Exposures US Equities
Apple, Skyworks Solutions And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals
McKesson earnings are on tap, with Cencora and Cardinal Health due soon. 
Via Investor's Business Daily
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
On Friday, the FDA issued a warning to consumers, cautioning them against the use of certain over-the-coun 
Via Benzinga
Exposures Product Safety
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
The U.S. 
Via Benzinga
Exposures Product Safety
The Best Blue Chip Dividend Stocks For Young Investors
Several economic factors, such as high inflation and rising interest rates, leave investors feeling skittish. For young investors, dividend stocks provide upside potential, portfolio stability, and... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
These three top-notch stocks would make great additions to any dividend portfolio. 
Via The Motley Fool
Top 3 Health Care Stocks That May Implode This Quarter
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
The Top 7 Stocks to Own During a Downturn
Investors tend to get jittery in October but these seven stocks to own during a downturn will protect your portfolio 
Via InvestorPlace
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.  
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.